Search Results

You are looking at 31 - 40 of 737 items for :

Clear All
Peter Wolf Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France
Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

Search for other papers by Peter Wolf in
Google Scholar
PubMed
Close
,
Alexandre Dormoy Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Alexandre Dormoy in
Google Scholar
PubMed
Close
,
Luigi Maione Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Luigi Maione in
Google Scholar
PubMed
Close
,
Sylvie Salenave Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Sylvie Salenave in
Google Scholar
PubMed
Close
,
Jacques Young Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Jacques Young in
Google Scholar
PubMed
Close
,
Peter Kamenický Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Peter Kamenický in
Google Scholar
PubMed
Close
, and
Philippe Chanson Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Philippe Chanson in
Google Scholar
PubMed
Close

Introduction Acromegaly results in a clinical syndrome following increased serum concentrations of growth hormone (GH) and insulin-like growth factor-1 (IGF-1). If not adequately treated, GH excess is associated with increased morbidity and

Open access
Krzysztof C Lewandowski Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland
Polish Mother’s Memorial Hospital–Research Institute, Lodz, Poland

Search for other papers by Krzysztof C Lewandowski in
Google Scholar
PubMed
Close
,
Justyna Płusajska Polish Mother’s Memorial Hospital–Research Institute, Lodz, Poland

Search for other papers by Justyna Płusajska in
Google Scholar
PubMed
Close
,
Wojciech Horzelski Faculty of Mathematics and Computer Science, University of Lodz, Lodz, Poland

Search for other papers by Wojciech Horzelski in
Google Scholar
PubMed
Close
,
Ewa Bieniek Polish Mother’s Memorial Hospital–Research Institute, Lodz, Poland

Search for other papers by Ewa Bieniek in
Google Scholar
PubMed
Close
, and
Andrzej Lewiński Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland
Polish Mother’s Memorial Hospital–Research Institute, Lodz, Poland

Search for other papers by Andrzej Lewiński in
Google Scholar
PubMed
Close

out. Though it is widely accepted that PCOS is characterised by insulin resistance ( 4 ), there is no consensus, either regarding the best method of assessment of insulin resistance (IR) in PCOS, nor in terms of the utility of such assessment for

Open access
Róża Aleksandrowicz Department of Prophylaxis of Metabolic Diseases, Bialystok, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland

Search for other papers by Róża Aleksandrowicz in
Google Scholar
PubMed
Close
and
Marek Strączkowski Department of Prophylaxis of Metabolic Diseases, Bialystok, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland

Search for other papers by Marek Strączkowski in
Google Scholar
PubMed
Close

secretion of many peptides ( 1 ). Skeletal muscle is the main metabolic tissue that uptakes about 85% of glucose in response to insulin stimulation via the glucose transporter type 4 (GLUT4). Therefore, disorders associated with lower sensitivity of skeletal

Open access
Alberto Battezzati International Center for the Assessment of Nutritional Status, DeFENS, University of Milan, Milan, Italy

Search for other papers by Alberto Battezzati in
Google Scholar
PubMed
Close
,
Andrea Foppiani International Center for the Assessment of Nutritional Status, DeFENS, University of Milan, Milan, Italy

Search for other papers by Andrea Foppiani in
Google Scholar
PubMed
Close
,
Gianfranco Alicandro Cystic Fibrosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy

Search for other papers by Gianfranco Alicandro in
Google Scholar
PubMed
Close
,
Arianna Bisogno Cystic Fibrosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy

Search for other papers by Arianna Bisogno in
Google Scholar
PubMed
Close
,
Arianna Biffi Cystic Fibrosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy

Search for other papers by Arianna Biffi in
Google Scholar
PubMed
Close
,
Giorgio Bedogni Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy
Internal Medicine, S. Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy

Search for other papers by Giorgio Bedogni in
Google Scholar
PubMed
Close
,
Simona Bertoli International Center for the Assessment of Nutritional Status, DeFENS, University of Milan, Milan, Italy
Istituto Auxologico Italiano, IRCCS, Obesity Unit - Laboratory of Nutrition and Obesity Research, Department of Endocrine and Metabolic Diseases, Milan, Italy

Search for other papers by Simona Bertoli in
Google Scholar
PubMed
Close
,
Giulia De Carlo International Center for the Assessment of Nutritional Status, DeFENS, University of Milan, Milan, Italy

Search for other papers by Giulia De Carlo in
Google Scholar
PubMed
Close
,
Erica Nazzari Cystic Fibrosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy

Search for other papers by Erica Nazzari in
Google Scholar
PubMed
Close
, and
Carla Colombo Cystic Fibrosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy

Search for other papers by Carla Colombo in
Google Scholar
PubMed
Close

Introduction Insulin secretory defects in cystic fibrosis (CF) were initially shown in small-sized studies that employed various sophisticated techniques such as the hyperglycemic clamp ( 1 , 2 , 3 ) and intravenous glucose tolerance test

Open access
Monika Karczewska-Kupczewska Department of Internal Medicine and Metabolic Diseases, Medical University of Białystok, Białystok, Poland

Search for other papers by Monika Karczewska-Kupczewska in
Google Scholar
PubMed
Close
,
Agnieszka Nikołajuk Department of Prophylaxis of Metabolic Diseases, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland

Search for other papers by Agnieszka Nikołajuk in
Google Scholar
PubMed
Close
,
Magdalena Stefanowicz Department of Metabolic Diseases, Medical University of Białystok, Białystok, Poland

Search for other papers by Magdalena Stefanowicz in
Google Scholar
PubMed
Close
,
Natalia Matulewicz Department of Metabolic Diseases, Medical University of Białystok, Białystok, Poland

Search for other papers by Natalia Matulewicz in
Google Scholar
PubMed
Close
,
Irina Kowalska Department of Internal Medicine and Metabolic Diseases, Medical University of Białystok, Białystok, Poland

Search for other papers by Irina Kowalska in
Google Scholar
PubMed
Close
, and
Marek Strączkowski Department of Prophylaxis of Metabolic Diseases, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland

Search for other papers by Marek Strączkowski in
Google Scholar
PubMed
Close

observed in different populations ( 8 , 11 , 13 ). Systemic chemerin levels were also found to be associated with markers of fatty liver disease ( 12 ). The main pathophysiological factor of obesity-related metabolic complications is insulin resistance

Open access
Jan W Eriksson Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Jan W Eriksson in
Google Scholar
PubMed
Close
,
Reem A Emad Department of Pharmacy, Uppsala University, Uppsala, Sweden

Search for other papers by Reem A Emad in
Google Scholar
PubMed
Close
,
Martin H Lundqvist Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Martin H Lundqvist in
Google Scholar
PubMed
Close
,
Niclas Abrahamsson Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Niclas Abrahamsson in
Google Scholar
PubMed
Close
, and
Maria C Kjellsson Department of Pharmacy, Uppsala University, Uppsala, Sweden

Search for other papers by Maria C Kjellsson in
Google Scholar
PubMed
Close

Introduction Development of type 2 diabetes has been perceived as a process that involves progressive insulin resistance in muscles, adipose tissue, and liver and a gradual failure of pancreatic beta cells to secrete sufficient amounts of

Open access
Rama Lakshman Wellcome-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK

Search for other papers by Rama Lakshman in
Google Scholar
PubMed
Close
,
Charlotte Boughton Wellcome-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK
Cambridge University Hospitals NHS Foundation Trust, Wolfson Diabetes and Endocrine Clinic, Cambridge, UK

Search for other papers by Charlotte Boughton in
Google Scholar
PubMed
Close
, and
Roman Hovorka Wellcome-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK

Search for other papers by Roman Hovorka in
Google Scholar
PubMed
Close

Introduction Over nine million people worldwide live with type 1 diabetes (T1D) ( 1 ). In this condition, immune-mediated destruction of pancreatic beta-cells leads to insulin deficiency and resultant hyperglycaemia. The management of T1D

Open access
M Boering Isala, Diabetes Centre, Zwolle, The Netherlands

Search for other papers by M Boering in
Google Scholar
PubMed
Close
,
P R van Dijk Isala, Diabetes Centre, Zwolle, The Netherlands
Isala, Department of Internal Medicine, Zwolle, The Netherlands

Search for other papers by P R van Dijk in
Google Scholar
PubMed
Close
,
S J J Logtenberg Diakonessenhuis, Department of Internal Medicine, Utrecht, The Netherlands
Langerhans Medical Research group, Zwolle, The Netherlands

Search for other papers by S J J Logtenberg in
Google Scholar
PubMed
Close
,
K H Groenier Isala, Diabetes Centre, Zwolle, The Netherlands
Department of General Practice, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Search for other papers by K H Groenier in
Google Scholar
PubMed
Close
,
B H R Wolffenbuttel Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Search for other papers by B H R Wolffenbuttel in
Google Scholar
PubMed
Close
,
R O B Gans Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Search for other papers by R O B Gans in
Google Scholar
PubMed
Close
,
N Kleefstra Isala, Diabetes Centre, Zwolle, The Netherlands
Langerhans Medical Research group, Zwolle, The Netherlands
Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Search for other papers by N Kleefstra in
Google Scholar
PubMed
Close
, and
H J G Bilo Isala, Diabetes Centre, Zwolle, The Netherlands
Isala, Department of Internal Medicine, Zwolle, The Netherlands
Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Search for other papers by H J G Bilo in
Google Scholar
PubMed
Close

Introduction Among type 1 diabetes mellitus (T1DM) patients, subcutaneous (SC) insulin administration is associated with low portal insulin concentrations and a consequent hepatic underinsulinization ( 1 ). Hepatic underinsulinization has been

Open access
Jakob Høgild Langdahl Department of Clinical Genetics, Odense University Hospital, Odense, Denmark
Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
Department of Endocrinology, Hospital of Southwest Jutland, Esbjerg, Denmark

Search for other papers by Jakob Høgild Langdahl in
Google Scholar
PubMed
Close
,
Anja Lisbeth Frederiksen Department of Clinical Genetics, Odense University Hospital, Odense, Denmark
Institute of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Anja Lisbeth Frederiksen in
Google Scholar
PubMed
Close
,
John Vissing Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, Copenhagen, Denmark

Search for other papers by John Vissing in
Google Scholar
PubMed
Close
,
Morten Frost Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark

Search for other papers by Morten Frost in
Google Scholar
PubMed
Close
,
Knud Bonnet Yderstræde Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark

Search for other papers by Knud Bonnet Yderstræde in
Google Scholar
PubMed
Close
, and
Per Heden Andersen Department of Endocrinology, Hospital of Southwest Jutland, Esbjerg, Denmark

Search for other papers by Per Heden Andersen in
Google Scholar
PubMed
Close

muscle is inversely correlated to age of diabetes debut ( 14 ). It is debated whether the impaired glucose metabolism in m.3243A>G carriers is characterized by insulin resistance, insulin secretion defect or a combination. The nuclear gene encoded

Open access
Esben Thyssen Vestergaard Medical Research Laboratories, Department of Endocrinology and Diabetes, Department of Pediatrics, Department of Endocrinology and Diabetes, Institute of Clinical Medicine, Aarhus University, Norrebrogade 44, DK-8000 Aarhus C, Denmark
Medical Research Laboratories, Department of Endocrinology and Diabetes, Department of Pediatrics, Department of Endocrinology and Diabetes, Institute of Clinical Medicine, Aarhus University, Norrebrogade 44, DK-8000 Aarhus C, Denmark
Medical Research Laboratories, Department of Endocrinology and Diabetes, Department of Pediatrics, Department of Endocrinology and Diabetes, Institute of Clinical Medicine, Aarhus University, Norrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Esben Thyssen Vestergaard in
Google Scholar
PubMed
Close
,
Morten B Krag Medical Research Laboratories, Department of Endocrinology and Diabetes, Department of Pediatrics, Department of Endocrinology and Diabetes, Institute of Clinical Medicine, Aarhus University, Norrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Morten B Krag in
Google Scholar
PubMed
Close
,
Morten M Poulsen Medical Research Laboratories, Department of Endocrinology and Diabetes, Department of Pediatrics, Department of Endocrinology and Diabetes, Institute of Clinical Medicine, Aarhus University, Norrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Morten M Poulsen in
Google Scholar
PubMed
Close
,
Steen B Pedersen Medical Research Laboratories, Department of Endocrinology and Diabetes, Department of Pediatrics, Department of Endocrinology and Diabetes, Institute of Clinical Medicine, Aarhus University, Norrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Steen B Pedersen in
Google Scholar
PubMed
Close
,
Niels Moller Medical Research Laboratories, Department of Endocrinology and Diabetes, Department of Pediatrics, Department of Endocrinology and Diabetes, Institute of Clinical Medicine, Aarhus University, Norrebrogade 44, DK-8000 Aarhus C, Denmark
Medical Research Laboratories, Department of Endocrinology and Diabetes, Department of Pediatrics, Department of Endocrinology and Diabetes, Institute of Clinical Medicine, Aarhus University, Norrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Niels Moller in
Google Scholar
PubMed
Close
,
Jens Otto Lunde Jorgensen Medical Research Laboratories, Department of Endocrinology and Diabetes, Department of Pediatrics, Department of Endocrinology and Diabetes, Institute of Clinical Medicine, Aarhus University, Norrebrogade 44, DK-8000 Aarhus C, Denmark
Medical Research Laboratories, Department of Endocrinology and Diabetes, Department of Pediatrics, Department of Endocrinology and Diabetes, Institute of Clinical Medicine, Aarhus University, Norrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Jens Otto Lunde Jorgensen in
Google Scholar
PubMed
Close
, and
Niels Jessen Medical Research Laboratories, Department of Endocrinology and Diabetes, Department of Pediatrics, Department of Endocrinology and Diabetes, Institute of Clinical Medicine, Aarhus University, Norrebrogade 44, DK-8000 Aarhus C, Denmark
Medical Research Laboratories, Department of Endocrinology and Diabetes, Department of Pediatrics, Department of Endocrinology and Diabetes, Institute of Clinical Medicine, Aarhus University, Norrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Niels Jessen in
Google Scholar
PubMed
Close

GHS-R is also located in peripheral tissues indicates that ghrelin also exerts direct peripheral effects (5, 6) . It has recently been reported that exogenous ghrelin causes insulin resistance (7, 8, 9, 10, 11) and induces lipolysis (7, 9, 10, 11

Open access